Brandi Reeves

16PUBLICATIONS
52CO-AUTHORS
Epidemiological methodsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 29, 2026
Exposure-Response Analyses of Ropeginterferon Alfa-2b in Essential Thrombocythemia.

|May 22, 2026
Long-term outcomes of ropeginterferon alfa-2b-njft in polycythemia vera: a review of safety, efficacy, and potential disease modification.

|Jul 08, 2024
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.

Ajai Chari, Jonathan L Kaufman, Jacob Laubach

|Apr 22, 2024
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.

Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman

|Apr 16, 2024
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN.

Rebecca Silbermann, Jacob Laubach, Jonathan L Kaufman

|Jul 14, 2023
Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.

Yohei Hisada, Tomohiro Kawano, Sierra J Archibald

Pageof 3

Frequent Collaborators

4 joint publications

Nigel S Key

4 joint publications

Paul G Richardson

4 joint publications

Jonathan L Kaufman

3 joint publications

Larry D Anderson